Key result
Concurrent supine hypertension and orthostatic hypotension are linked to ~41% lower adrenergic baroreflex sensitivity.
Why the study?
Pharmacological interventions do not restore normal baroreflex control in elderly patients with orthostatic hypotension and supine hypertension, creating a need to define the relationship between impaired baroreflex responses and autonomic biomarkers targeted by heart rate variability biofeedback.
What is the relationship between heart rate variability biomarkers (SDNN and LF-HRV) and impaired adrenergic and vagal baroreflex responses during the Valsalva maneuver and head-up tilt in elderly patients with systolic orthostatic hypotension and/or supine hypertension?
Observational (n=273)
No
What is the relationship between heart rate variability biomarkers (SDNN and LF-HRV) and impaired adrenergic and vagal baroreflex responses during the Valsalva maneuver and head-up tilt in elderly patients with systolic orthostatic hypotension and/or supine hypertension?
This study demonstrates that in elderly patients, heart rate variability biomarkers (SDNN and LF-HRV) strongly correlate with distinct adrenergic and vagal baroreflex deficits underlying systolic orthostatic hypotension and supine hypertension, supporting their utility as physiological targets for nonpharmacological HRV biofeedback interventions.
SH with sOH linked to reduced baroreflex sensitivity; hypothesis-generating and should not yet change practice.
Orthostatic hypotension (OH) and supine hypertension (SH) are physiological indicators of autonomic dysfunction that are associated with an increased risk of major cerebrocardiovascular events. Since pharmacological interventions do not restore normal baroreflex control, improving the efficacy of nonpharmacological interventions that are suitable for these at-risk populations is needed. Heart rate variability (HRV) biofeedback (HRVB) intervention is a safe option to effectively target cardiovascular autonomic regulation and the baroreflex in this patient population. The objective of this study was to determine in elderly patients the relationship between autonomic biomarkers known to be increased by HRVB and impaired baroreflex responses in patients with systolic OH (sOH) and/or SH. This is a retrospective study of 273 patients (144 women; Age: 65–94 yrs) evaluated with a standardized testing protocol of the Autonomic Reflex Screen from 2015 to 2022. Analyses were performed to determine HRV indices and adrenal (BRS a ) and vagal (BRS v ) baroreflex responses during the Valsalva maneuver (VM). The study demonstrated that sOH was associated with a reduction in HRV metrics and the BRS a , independent of SH. This study also demonstrated that SH was associated with a significant increase in Phase II E of the VM and a reduction in the BRS v , independent of sOH. Our results also showed that deficits in Phase II L of the VM were only observed in patients with sOH and concurrent SH. These findings suggest a significant relationship between biomarkers known to improve with HRVB (SDNN and LF-HRV) and deficits in hemodynamic fluctuations in VM contributing to sOH and SH.
No takes yet. Share an insight, caveat, or question.
Criado et al. (2026) conducted an observational in Systolic orthostatic hypotension and supine hypertension (n=273). Concurrent supine hypertension and systolic orthostatic hypotension (SH/sOH) vs. No supine hypertension and no systolic orthostatic hypotension (No SH/No sOH) was evaluated on Adrenergic baroreflex sensitivity (BRSa, mmHg/s) during the Valsalva maneuver (p=<0.05). Concurrent supine hypertension and systolic orthostatic hypotension reduced adrenergic (11.2 vs 18.9 mmHg/s) and vagal (2.6 vs 3.5 ms/mmHg) baroreflex sensitivity compared to controls (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: